{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T11:40:06Z","timestamp":1746358806567,"version":"3.40.4"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["atherosclerosis-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.atherosclerosis.2014.07.033","type":"journal-article","created":{"date-parts":[[2014,8,27]],"date-time":"2014-08-27T17:31:09Z","timestamp":1409160669000},"page":"38-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Relationship between dimethylarginine dimethylaminohydrolase gene variants and asymmetric dimethylarginine in patients with rheumatoid arthritis"],"prefix":"10.1016","volume":"237","author":[{"given":"Theodoros","family":"Dimitroulas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aamer","family":"Sandoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Hodson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasileios F.","family":"Panoulas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George D.","family":"Kitas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/ard.2010.142133","article-title":"Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives","volume":"7","author":"Kitas","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib2","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1136\/annrheumdis-2011-200726","article-title":"Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies","volume":"71","author":"Avina-Zubieta","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"10 Suppl.\u00a01","key":"10.1016\/j.atherosclerosis.2014.07.033_bib3","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.amjmed.2008.06.014","article-title":"Role of inflammation in atherosclerosis associated with rheumatoid arthritis","volume":"121","author":"Libby","year":"2008","journal-title":"Am J Med"},{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib4","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1093\/rheumatology\/ker275","article-title":"Vascular function and morphology in rheumatoid arthritis: a systematic review","volume":"50","author":"Sandoo","year":"2011","journal-title":"Rheumatol (Oxford)"},{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.semarthrit.2005.03.004","article-title":"Rheumatoid arthritis: a disease associated with accelerated atherogenesis","volume":"35","author":"Gonzalez-Gay","year":"2005","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib6","doi-asserted-by":"crossref","DOI":"10.1186\/ar4335","article-title":"The ZC3HC1 rs11556924 polymorphism is associated with increased carotid intima-media thickness in patients with rheumatoid arthritis","volume":"15","author":"L\u00f3pez-Mej\u00edas","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.atherosclerosis.2010.10.052","article-title":"TNFA -308 (rs1800629) polymorphism is associated with a higher risk of cardiovascular disease in patients with rheumatoid arthritis","volume":"216","author":"Rodr\u00edguez-Rodr\u00edguez","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib8","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.atherosclerosis.2012.06.008","article-title":"NFKB1-94ATTG ins\/del polymorphism (rs28362491) is associated with cardiovascular disease in patients with rheumatoid arthritis","volume":"224","author":"L\u00f3pez-Mej\u00edas","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib9","doi-asserted-by":"crossref","first-page":"302","DOI":"10.2174\/1874192401004010302","article-title":"The endothelium and its role in regulating vascular tone","volume":"4","author":"Sandoo","year":"2010","journal-title":"Open Cardiovasc Med J"},{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib10","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1161\/ATVBAHA.111.228833","article-title":"DDAH says NO to ADMA","volume":"31","author":"Cooke","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib11","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1161\/01.ATV.0000128897.54893.26","article-title":"Cardiovascular biology of the asymmetric dimethylarginine:dimethylarginine dimethylaminohydrolase pathway","volume":"24","author":"Vallance","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib12","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1161\/ATVBAHA.112.247726","article-title":"Endogenous nitric oxide synthase inhibitors in the biology of disease: markers, mediators, and regulators?","volume":"32","author":"Caplin","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib13","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ijcard.2008.12.131","article-title":"Endothelial dysfunction, ADMA and insulin resistance in essential hypertension","volume":"142","author":"Perticone","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib14","doi-asserted-by":"crossref","first-page":"12315","DOI":"10.3390\/ijms131012315","article-title":"Asymmetric dimethylarginine as a surrogate marker of endothelial dysfunction and cardiovascular risk in patients with systemic rheumatic diseases","volume":"13","author":"Dimitroulas","year":"2012","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib15","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijcard.2011.06.120","article-title":"Plasma asymmetric dimethylarginine predicts death and major adverse cardiovascular events in individuals referred for coronary angiography","volume":"153","author":"Lu","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib16","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1161\/CIRCULATIONAHA.108.838268","article-title":"Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community","volume":"119","author":"B\u00f6ger","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib17","first-page":"388","article-title":"Lack of association between asymmetric dimethylarginine and in\u00a0vivo microvascular and macrovascular endothelial function in patients with rheumatoid arthritis","volume":"30","author":"Sandoo","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib18","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/art.22424","article-title":"Elevated plasma asymmetric dimethyl-L-arginine levels are linked to endothelial progenitor cell depletion and carotid atherosclerosis in rheumatoid arthritis","volume":"56","author":"Surdacki","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib19","doi-asserted-by":"crossref","first-page":"169","DOI":"10.5505\/tjb.2013.51523","article-title":"Asymmetric dimethylarginine and arginine levels in patients with rheumatoid arthritis","volume":"38","author":"Vatansev","year":"2013","journal-title":"Turk J Biochem"},{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib20","doi-asserted-by":"crossref","first-page":"270","DOI":"10.20452\/pamw.1277","article-title":"Plasma asymmetric dimethylarginine in active rheumatoid arthritis: links with oxidative stress and inflammation","volume":"122","author":"Kwa\u015bny-Krochin","year":"2012","journal-title":"Pol Arch Med Wewn"},{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib21","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.clinbiochem.2012.07.092","article-title":"Clinical remission following treatment with tumour necrosis factor-alpha antagonists is not accompanied by changes in asymmetric dimethylarginine in patients with rheumatoid arthritis","volume":"45","author":"Sandoo","year":"2012","journal-title":"Clin Biochem"},{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib22","first-page":"749","article-title":"Asymmetric dimethylarginine serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-\u03b1 antagonist therapy","volume":"31","author":"Genre","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib23","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1161\/01.ATV.0000081742.92006.59","article-title":"Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase","volume":"23","author":"Achan","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1006\/geno.2000.6262","article-title":"Chromosomal localization, gene structure, and expression pattern of DDAH1: comparison with DDAH2 and implications for evolutionary origins","volume":"68","author":"Tran","year":"2000","journal-title":"Genomics"},{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib25","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1161\/CIRCULATIONAHA.108.819912","article-title":"Vascular endothelial-specific dimethylarginine dimethylaminohydrolase-1-deficient mice reveal that vascular endothelium plays an important role in removing asymmetric dimethylarginine","volume":"120","author":"Hu","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib26","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nm1543","article-title":"Disruption of methylarginine metabolism impairs vascular homeostasis","volume":"13","author":"Leiper","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib27","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1161\/01.CIR.0000101924.04515.2E","article-title":"Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence","volume":"108","author":"Dayoub","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.atherosclerosis.2013.08.041","article-title":"A\u00a0functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with chronic kidney disease","volume":"231","author":"Sesti","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib29","doi-asserted-by":"crossref","first-page":"e36224","DOI":"10.1371\/journal.pone.0036224","article-title":"A\u00a0functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with insulin sensitivity","volume":"7","author":"Andreozzi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib30","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1161\/ATVBAHA.110.222638","article-title":"Dimethylarginine dimethylaminohydrolase-1 is the critical enzyme for degrading the cardiovascular risk factor asymmetrical dimethylarginine","volume":"31","author":"Hu","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib31","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.intimp.2013.04.009","article-title":"Involvement of DDAH\/ADMA pathway in the pathogenesis of rheumatoid arthritis in rats","volume":"16","author":"Chen","year":"2013","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib32","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib33","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib34","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/art.24176","article-title":"Association of the TRAF1\/C5 locus with increased mortality, particularly from malignancy or sepsis, in patients with rheumatoid arthritis","volume":"60","author":"Panoulas","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib35","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","article-title":"Haploview: analysis and visualization of LD and haplotype maps","volume":"21","author":"Barrett","year":"2005","journal-title":"Bioinformatics"},{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib36","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1177\/1358863X13496488","article-title":"Genetic variation in the dimethylarginine dimethylaminohydrolase 1 gene (DDAH1) is related to asymmetric dimethylarginine (ADMA) levels, but not to endothelium-dependent vasodilation","volume":"18","author":"Lind","year":"2013","journal-title":"Vasc Med"},{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib37","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/ki.2009.463","article-title":"Circulating methylarginine levels and the decline in renal function in patients with chronic kidney disease are modulated by DDAH1 polymorphisms","volume":"77","author":"Caplin","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib38","doi-asserted-by":"crossref","first-page":"e9462","DOI":"10.1371\/journal.pone.0009462","article-title":"Sequence variation in DDAH1 and DDAH2 genes is strongly and additively associated with serum ADMA concentrations in individuals with type 2 diabetes","volume":"5","author":"Abhary","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib39","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jdiacomp.2012.03.022","article-title":"Relationship between DDAH gene variants and serum ADMA level in individuals with type 1 diabetes","volume":"26","author":"Fogarty","year":"2012","journal-title":"J\u00a0Diabetes Complications"},{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib40","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1136\/ard.2010.145839","article-title":"Cardiovascular risk in rheumatoid arthritis and diabetes: how does it compare and when does it start?","volume":"70","author":"Nurmohamed","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib41","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S0002-9149(01)02063-X","article-title":"Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus","volume":"88","author":"Abbasi","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib42","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1055\/s-0028-1083814","article-title":"Asymmetric dimethylarginine (ADMA) and other endogenous nitric oxide synthase (NOS) inhibitors as an important cause of vascular insulin resistance","volume":"40","author":"Toutouzas","year":"2008","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib43","doi-asserted-by":"crossref","first-page":"e60653","DOI":"10.1371\/journal.pone.0060653","article-title":"FXR agonist INT-747 upregulates DDAH expression and enhances insulin sensitivity in high-salt fed dahl rats","volume":"8","author":"Ghebremariam","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib44","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3109\/03009742.2012.747627","article-title":"Predictors of asymmetric dimethylarginine levels in patients with rheumatoid arthritis: the role of insulin resistance","volume":"42","author":"Dimitroulas","year":"2013","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib45","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.atherosclerosis.2012.08.033","article-title":"The L-arginine\/asymmetric dimethylarginine ratio is improved by anti-tumor necrosis factor-\u03b1 therapy in inflammatory arthropathies. Associations with aortic stiffness","volume":"225","author":"Angel","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib46","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ijcard.2013.12.235","article-title":"Asymmetric dimethylarginine is not associated with subendocardial viability ratio in rheumatoid Arthritis","volume":"172","author":"Dimitroulas","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib47","first-page":"e53","article-title":"Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study","volume":"97","author":"Schnabel","year":"2005","journal-title":"CircRes"},{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib48","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.vph.2005.09.005","article-title":"Lysophosphatidylcholine induced elevation of asymmetric dimethylarginine level by the NADPH oxidase pathway in endothelial cells","volume":"44","author":"Jia","year":"2006","journal-title":"Vasc Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib49","doi-asserted-by":"crossref","first-page":"13527","DOI":"10.1073\/pnas.212269799","article-title":"S-nitrosylation of dimethylarginine dimethylaminohydrolase regulates enzyme activity: further interactions between nitric oxide synthase and dimethylarginine dimethylaminohydrolase","volume":"99","author":"Leiper","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib50","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.2174\/13816128113196660748","article-title":"eNOS uncoupling in cardiovascular diseases - the role of oxidative stress and inflammation","volume":"20","author":"Karbach","year":"2014","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib51","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1159\/000103284","article-title":"Role of asymmetric dimethylarginine in inflammatory reactions by angiotensin II","volume":"44","author":"Chen","year":"2007","journal-title":"J\u00a0Vasc Res"},{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib52","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/1479164110366053","article-title":"Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: an intriguing interaction with diabetes mellitus","volume":"7","author":"Anderssohn","year":"2010","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib53","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.atherosclerosis.2009.05.011","article-title":"Methylarginines and mortality in patients with end stage renal disease: a prospective cohort study","volume":"207","author":"Aucella","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2014.07.033_bib54","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.metabol.2008.10.002","article-title":"Plasma asymmetric dimethylarginine is related to anticitrullinated protein antibodies in rheumatoid arthritis of short duration","volume":"58","author":"Surdacki","year":"2009","journal-title":"Metabolism"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915014013434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915014013434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T10:59:54Z","timestamp":1746356394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915014013434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0021915014013434"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.07.033","relation":{},"ISSN":["0021-9150"],"issn-type":[{"type":"print","value":"0021-9150"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship between dimethylarginine dimethylaminohydrolase gene variants and asymmetric dimethylarginine in patients with rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.07.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}